Cyclophilin F antibody [N1C3]
GTX117951
ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
TargetPPIF
Overview
- SupplierGeneTex
- Product NameCyclophilin F antibody [N1C3]
- Delivery Days Customer9
- Application Supplier NoteWB: 1:500-1:10000. ICC/IF: 1:100-1:1000. IHC-P: 1:100-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration0.67 mg/ml
- ConjugateUnconjugated
- Gene ID10105
- Target namePPIF
- Target descriptionpeptidylprolyl isomerase F
- Target synonymsCYP3, CyP-M, Cyp-D, CypD, peptidyl-prolyl cis-trans isomerase F, mitochondrial, PPIase F, cyclophilin 3, cyclophilin D, cyclophilin F, mitochondrial cyclophilin, peptidyl-prolyl cis-trans isomerase, mitochondrial, rotamase F
- HostRabbit
- IsotypeIgG
- Protein IDP30405
- Protein NamePeptidyl-prolyl cis-trans isomerase F, mitochondrial
- Scientific DescriptionThe protein encoded by this gene is a member of the peptidyl-prolyl cis-trans isomerase (PPIase) family. PPIases catalyze the cis-trans isomerization of proline imidic peptide bonds in oligopeptides and accelerate the folding of proteins. This protein is part of the mitochondrial permeability transition pore in the inner mitochondrial membrane. Activation of this pore is thought to be involved in the induction of apoptotic and necrotic cell death. [provided by RefSeq]
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Ogawa T, Kouzu H, Osanami A, et al. Downregulation of extramitochondrial BCKDH and its uncoupling from AMP deaminase in type 2 diabetic OLETF rat hearts. Physiol Rep. 2023,11(4):e15608. doi: 10.14814/phy2.15608Read this paper
- Anderson DE, Cui J, Ye Q, et al. Orthogonal genome-wide screens of bat cells identify MTHFD1 as a target of broad antiviral therapy. Proc Natl Acad Sci U S A. 2021,118(39). doi: 10.1073/pnas.2104759118Read this paper




